From: NIDA Neuro Science Interest Group [mailto:NIDA_NEURO_SCIENCE-L@LIST.NIH.GOV] On Behalf Of NIDA NEURO SCIENCE (NIH/NIDA)
Sent: Friday, December 07, 2012 3:48 PM
Subject: NIH PA-13-018 Administrative Supplements for Research on Sex/Gender Differences (Admin Supp)
The NIH Office of Research on Women’s Health (ORWH) and participating ICs including NIDA released on November 13 the FOA, PA-13-018 Administrative Supplements for Research on Sex/Gender Differences (Admin Supp). Supplements will be funded by an ORWH set aside. The earliest submission date is December 12, 2012 and the application due date is January 11, 2013.
As is the case for all administrative supplements, research proposed under this announcement must be within the original scope of the parent grant. Applicants should propose research that, if successful, would contribute to a greater understanding of the implications of sex/gender differences (or similarities) in human health or disease outcomes. Applicants may use the following approaches to address sex/gender comparisons:
- The addition of another group of subjects (human or animal) of the opposite sex when subjects of only one sex were used in the original study for comparative analyses of sex/gender. Applicants proposing to use subjects of only one sex/gender will be considered non-responsive UNLESS the data will be compared with those from the opposite sex within the administrative supplement period;
- The addition of more subjects (human or animal) of both sexes to sufficiently power a study that was insufficiently powered to conduct or detect a sex/gender difference (or similarity) in the original study; or
- The analyses of preexisting data where sex-specific data are included and power is sufficient, but a sex/gender analysis was not performed as part of the original study.
The National Institute on Drug Abuse (NIDA) at the National Institutes of Health is an agency of the United States Department of Health and Human Services